Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Cerium oxide nanoparticles improve liver regeneration after acetaminophen-induced liver injury and partial hepatectomy in rats.

Córdoba-Jover B, Arce-Cerezo A, Ribera J, Pauta M, Oró D, Casals G, Fernández-Varo G, Casals E, Puntes V, Jiménez W, Morales-Ruiz M.

J Nanobiotechnology. 2019 Oct 31;17(1):112. doi: 10.1186/s12951-019-0544-5.

2.

Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease.

Carvajal S, Perramón M, Oró D, Casals E, Fernández-Varo G, Casals G, Parra M, González de la Presa B, Ribera J, Pastor Ó, Morales-Ruíz M, Puntes V, Jiménez W.

Sci Rep. 2019 Sep 6;9(1):12848. doi: 10.1038/s41598-019-49262-2.

3.

Beyond the Scavenging of Reactive Oxygen Species (ROS): Direct Effect of Cerium Oxide Nanoparticles in Reducing Fatty Acids Content in an In Vitro Model of Hepatocellular Steatosis.

Parra-Robert M, Casals E, Massana N, Zeng M, Perramón M, Fernández-Varo G, Morales-Ruiz M, Puntes V, Jiménez W, Casals G.

Biomolecules. 2019 Aug 29;9(9). pii: E425. doi: 10.3390/biom9090425.

4.

Metastatic Tissue Proteomic Profiling Predicts 5-Year Outcomes in Patients with Colorectal Liver Metastases.

Marfà S, Marti J, Reyes A, Casals G, Fernández-Varo G, Carvajal S, García-Valdecasas JC, Fuster J, Jiménez W.

Transl Oncol. 2016 Oct;9(5):445-452. doi: 10.1016/j.tranon.2016.08.002.

5.

Sipa1l1 is an early biomarker of liver fibrosis in CCl4-treated rats.

Marfà S, Morales-Ruiz M, Oró D, Ribera J, Fernández-Varo G, Jiménez W.

Biol Open. 2016 Jun 15;5(6):858-65. doi: 10.1242/bio.018887.

6.

Cerium oxide nanoparticles reduce steatosis, portal hypertension and display anti-inflammatory properties in rats with liver fibrosis.

Oró D, Yudina T, Fernández-Varo G, Casals E, Reichenbach V, Casals G, González de la Presa B, Sandalinas S, Carvajal S, Puntes V, Jiménez W.

J Hepatol. 2016 Mar;64(3):691-8. doi: 10.1016/j.jhep.2015.10.020. Epub 2015 Oct 28.

PMID:
26519601
7.

Vasopressin 1a receptor partial agonism increases sodium excretion and reduces portal hypertension and ascites in cirrhotic rats.

Fernández-Varo G, Oró D, Cable EE, Reichenbach V, Carvajal S, de la Presa BG, Wiśniewski K, Ginés P, Harris G, Jiménez W.

Hepatology. 2016 Jan;63(1):207-16. doi: 10.1002/hep.28250. Epub 2015 Nov 4.

PMID:
26403564
8.

Overexpression of angiopoietin-2 in rats and patients with liver fibrosis. Therapeutic consequences of its inhibition.

Pauta M, Ribera J, Melgar-Lesmes P, Casals G, Rodríguez-Vita J, Reichenbach V, Fernandez-Varo G, Morales-Romero B, Bataller R, Michelena J, Altamirano J, Jiménez W, Morales-Ruiz M.

Liver Int. 2015 Apr;35(4):1383-92. doi: 10.1111/liv.12505. Epub 2014 Mar 11.

PMID:
24612347
9.

Factors involved in extracellular matrix turnover in human derived cardiomyocytes.

Casals G, Fernández-Varo G, Melgar-Lesmes P, Marfà S, Reichenbach V, Morales-Ruiz M, Jiménez W.

Cell Physiol Biochem. 2013;32(5):1125-36. doi: 10.1159/000354513. Epub 2013 Nov 11.

10.

Bacterial lipopolyshaccaride inhibits CB2 receptor expression in human monocytic cells.

Reichenbach V, Muñoz-Luque J, Ros J, Casals G, Navasa M, Fernández-Varo G, Morales-Ruiz M, Jiménez W.

Gut. 2013 Jul;62(7):1089-91. doi: 10.1136/gutjnl-2012-303662. Epub 2013 Jan 24. No abstract available.

PMID:
23348962
11.

[Serological markers of fibrosis].

Fernández-Varo G.

Gastroenterol Hepatol. 2012 Dec;35 Suppl 2:10-6. doi: 10.1016/S0210-5705(12)70044-4. Spanish.

PMID:
23298654
12.

Adenoviral dominant-negative soluble PDGFRβ improves hepatic collagen, systemic hemodynamics, and portal pressure in fibrotic rats.

Reichenbach V, Fernández-Varo G, Casals G, Oró D, Ros J, Melgar-Lesmes P, Weiskirchen R, Morales-Ruiz M, Jiménez W.

J Hepatol. 2012 Nov;57(5):967-73. doi: 10.1016/j.jhep.2012.07.012. Epub 2012 Jul 20.

PMID:
22820479
13.

ARFI, FibroScan, ELF, and their combinations in the assessment of liver fibrosis: a prospective study.

Crespo G, Fernández-Varo G, Mariño Z, Casals G, Miquel R, Martínez SM, Gilabert R, Forns X, Jiménez W, Navasa M.

J Hepatol. 2012 Aug;57(2):281-7. doi: 10.1016/j.jhep.2012.03.016. Epub 2012 Apr 17.

PMID:
22521355
14.

Increased nitric oxide production in lymphatic endothelial cells causes impairment of lymphatic drainage in cirrhotic rats.

Ribera J, Pauta M, Melgar-Lesmes P, Tugues S, Fernández-Varo G, Held KF, Soria G, Tudela R, Planas AM, Fernández-Hernando C, Arroyo V, Jiménez W, Morales-Ruiz M.

Gut. 2013 Jan;62(1):138-45. doi: 10.1136/gutjnl-2011-300703. Epub 2012 Jan 20.

PMID:
22267600
15.

Prevention of fibrosis progression in CCl4-treated rats: role of the hepatic endocannabinoid and apelin systems.

Reichenbach V, Ros J, Fernández-Varo G, Casals G, Melgar-Lesmes P, Campos T, Makriyannis A, Morales-Ruiz M, Jiménez W.

J Pharmacol Exp Ther. 2012 Mar;340(3):629-37. doi: 10.1124/jpet.111.188078. Epub 2011 Dec 7.

PMID:
22160265
16.

Effects of pentoxifylline on intestinal bacterial overgrowth, bacterial translocation and spontaneous bacterial peritonitis in cirrhotic rats with ascites.

Corradi F, Brusasco C, Fernández J, Vila J, Ramirez MJ, Seva-Pereira T, Fernández-Varo G, Mosbah IB, Acevedo J, Silva A, Rocco PR, Pelosi P, Gines P, Navasa M.

Dig Liver Dis. 2012 Mar;44(3):239-44. doi: 10.1016/j.dld.2011.10.014. Epub 2011 Nov 25.

PMID:
22119621
17.

Circulating CO3-610, a degradation product of collagen III, closely reflects liver collagen and portal pressure in rats with fibrosis.

Segovia-Silvestre T, Reichenbach V, Fernández-Varo G, Vassiliadis E, Barascuk N, Morales-Ruiz M, Karsdal MA, Jiménez W.

Fibrogenesis Tissue Repair. 2011 Aug 3;4:19. doi: 10.1186/1755-1536-4-19.

18.

Assessment of liver fibrosis before and after antiviral therapy by different serum marker panels in patients with chronic hepatitis C.

Martinez SM, Fernández-Varo G, González P, Sampson E, Bruguera M, Navasa M, Jiménez W, Sánchez-Tapias JM, Forns X.

Aliment Pharmacol Ther. 2011 Jan;33(1):138-48. doi: 10.1111/j.1365-2036.2010.04500.x. Epub 2010 Oct 26.

19.

Inactivation of extrahepatic vascular Akt improves systemic hemodynamics and sodium excretion in cirrhotic rats.

Fernández-Varo G, Melgar-Lesmes P, Casals G, Pauta M, Arroyo V, Morales-Ruiz M, Ros J, Jiménez W.

J Hepatol. 2010 Dec;53(6):1041-8. doi: 10.1016/j.jhep.2010.05.031. Epub 2010 Aug 3.

PMID:
20800923
20.

Serum fibrosis markers identify patients with mild and progressive hepatitis C recurrence after liver transplantation.

Carrión JA, Fernández-Varo G, Bruguera M, García-Pagán JC, García-Valdecasas JC, Pérez-Del-Pulgar S, Forns X, Jiménez W, Navasa M.

Gastroenterology. 2010 Jan;138(1):147-58.e1. doi: 10.1053/j.gastro.2009.09.047. Epub 2009 Sep 26.

PMID:
19786026
21.

Vascular endothelial growth factor and angiopoietin-2 play a major role in the pathogenesis of vascular leakage in cirrhotic rats.

Melgar-Lesmes P, Tugues S, Ros J, Fernández-Varo G, Morales-Ruiz M, Rodés J, Jiménez W.

Gut. 2009 Feb;58(2):285-92. doi: 10.1136/gut.2008.155028. Epub 2008 Oct 31.

PMID:
18978178
22.

The hepatic apelin system: a new therapeutic target for liver disease.

Principe A, Melgar-Lesmes P, Fernández-Varo G, del Arbol LR, Ros J, Morales-Ruiz M, Bernardi M, Arroyo V, Jiménez W.

Hepatology. 2008 Oct;48(4):1193-201. doi: 10.1002/hep.22467.

PMID:
18816630
23.

Bradykinin attenuates hepatocellular damage and fibrosis in rats with chronic liver injury.

Sancho-Bru P, Bataller R, Fernandez-Varo G, Moreno M, Ramalho LN, Colmenero J, Marí M, Clària J, Jiménez W, Arroyo V, Brenner DA, Ginès P.

Gastroenterology. 2007 Dec;133(6):2019-28. Epub 2007 Sep 26.

PMID:
18054572
24.

Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats.

Muñoz-Luque J, Ros J, Fernández-Varo G, Tugues S, Morales-Ruiz M, Alvarez CE, Friedman SL, Arroyo V, Jiménez W.

J Pharmacol Exp Ther. 2008 Feb;324(2):475-83. Epub 2007 Nov 20.

25.

Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats.

Tugues S, Fernandez-Varo G, Muñoz-Luque J, Ros J, Arroyo V, Rodés J, Friedman SL, Carmeliet P, Jiménez W, Morales-Ruiz M.

Hepatology. 2007 Dec;46(6):1919-26.

PMID:
17935226
26.

Impaired extracellular matrix degradation in aortic vessels of cirrhotic rats.

Fernández-Varo G, Morales-Ruiz M, Ros J, Tugues S, Muñoz-Luque J, Casals G, Arroyo V, Rodés J, Jiménez W.

J Hepatol. 2007 Mar;46(3):440-6. Epub 2006 Nov 13.

PMID:
17156884
27.

Microarray analysis of endothelial differentially expressed genes in liver of cirrhotic rats.

Tugues S, Morales-Ruiz M, Fernandez-Varo G, Ros J, Arteta D, Muñoz-Luque J, Arroyo V, Rodés J, Jiménez W.

Gastroenterology. 2005 Nov;129(5):1686-95.

PMID:
16285966
28.

Sustained aquaretic effect of the V2-AVP receptor antagonist, RWJ-351647, in cirrhotic rats with ascites and water retention.

Ros J, Fernández-Varo G, Muñoz-Luque J, Arroyo V, Rodés J, Gunnet JW, Demarest KT, Jiménez W.

Br J Pharmacol. 2005 Nov;146(5):654-61.

29.

The role of nitric oxide in the pathogenesis of systemic and splanchnic vasodilation in cirrhotic rats before and after the onset of ascites.

Angeli P, Fernández-Varo G, Dalla Libera V, Fasolato S, Galioto A, Arroyo V, Sticca A, Guarda S, Gatta A, Jiménez W.

Liver Int. 2005 Apr;25(2):429-37.

PMID:
15780069
30.

Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors.

Domenicali M, Ros J, Fernández-Varo G, Cejudo-Martín P, Crespo M, Morales-Ruiz M, Briones AM, Campistol JM, Arroyo V, Vila E, Rodés J, Jiménez W.

Gut. 2005 Apr;54(4):522-7.

31.

Sodium retention in cirrhotic rats is associated with increased renal abundance of sodium transporter proteins.

Fernández-Llama P, Ageloff S, Fernández-Varo G, Ros J, Wang X, Garra N, Esteva-Font C, Ballarin J, Barcelo P, Arroyo V, Stokes JB, Knepper MA, Jiménez W.

Kidney Int. 2005 Feb;67(2):622-30.

32.

Sialoadenectomy alters liver cell turn-over and function in mice.

Buira I, Poch E, Sánchez O, Fernández-Varo G, Grau M, Tebar F, Ramírez I, Soley M.

J Cell Physiol. 2004 Jan;198(1):12-21.

PMID:
14584039
33.

Transduction of the liver with activated Akt normalizes portal pressure in cirrhotic rats.

Morales-Ruiz M, Cejudo-Martín P, Fernández-Varo G, Tugues S, Ros J, Angeli P, Rivera F, Arroyo V, Rodés J, Sessa WC, Jiménez W.

Gastroenterology. 2003 Aug;125(2):522-31.

PMID:
12891555
34.

Effect of the V1a/V2-AVP receptor antagonist, Conivaptan, on renal water metabolism and systemic hemodynamics in rats with cirrhosis and ascites.

Fernández-Varo G, Ros J, Cejudo-Martín P, Cano C, Arroyo V, Rivera F, Rodés J, Jiménez W.

J Hepatol. 2003 Jun;38(6):755-61.

PMID:
12763368
35.

Nitric oxide synthase 3-dependent vascular remodeling and circulatory dysfunction in cirrhosis.

Fernández-Varo G, Ros J, Morales-Ruiz M, Cejudo-Martín P, Arroyo V, Solé M, Rivera F, Rodés J, Jiménez W.

Am J Pathol. 2003 Jun;162(6):1985-93.

36.

Hypoxia is an inducer of vasodilator agents in peritoneal macrophages of cirrhotic patients.

Cejudo-Martín P, Morales-Ruiz M, Ros J, Navasa M, Fernández-Varo G, Fuster J, Rivera F, Arroyo V, Rodés J, Jiménez W.

Hepatology. 2002 Nov;36(5):1172-9.

PMID:
12395327
37.

Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat.

Ros J, Clària J, To-Figueras J, Planagumà A, Cejudo-Martín P, Fernández-Varo G, Martín-Ruiz R, Arroyo V, Rivera F, Rodés J, Jiménez W.

Gastroenterology. 2002 Jan;122(1):85-93.

PMID:
11781284
38.

Increased production of vascular endothelial growth factor in peritoneal macrophages of cirrhotic patients with spontaneous bacterial peritonitis.

Cejudo-Martín P, Ros J, Navasa M, Fernández J, Fernández-Varo G, Ruiz-del-Arbol L, Rivera F, Arroyo V, Rodés J, Jiménez W.

Hepatology. 2001 Sep;34(3):487-93.

PMID:
11526533

Supplemental Content

Loading ...
Support Center